Rufinamide

Code: R-023-1ML D2-231

Application

An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and child...


 Read more

Your Price
€163.17 1ML
€200.70 inc. VAT
REQUEST

Application

An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older.

General description

An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older. Rufinamide is marketed as Banzel® in the US and Inovelon® in the EU.

Legal Information

Snap-N-Spike is a registered trademark of Cerilliant Corporation

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

CERILLIANT is a registered trademark of Cerilliant Corporation

application(s)clinical testing
concentration1.0 mg/mL in acetonitrile: water (9:1)
featureSnap-N-Spike®/Snap-N-Shoot®
formliquid
formatsingle component solution
gradecertified reference material
InChI keyPOGQSBRIGCQNEG-UHFFFAOYSA-N
InChI1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17)
manufacturer/tradenameCerilliant®
packagingampule of 1 mL
Quality Level300
SMILES stringNC(=O)c1cn(Cc2c(F)cccc2F)nn1
storage temp.−20°C
technique(s)gas chromatography (GC): suitable, liquid chromatography (LC): suitable
Cas Number106308-44-5
Hazard Class3
Un Number1648
Pack GroupII
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN
GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.